{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T13:44:22Z","timestamp":1788270262346,"version":"build-2803163510"},"reference-count":49,"publisher":"Journal of Neurosurgery Publishing Group (JNSPG)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JNS"],"published-print":{"date-parts":[[2016,1]]},"abstract":"\nOBJECT<\/jats:title>\nAlthough cerebral vasospasm (CV) is one of the most important predictors for the outcome in patients with subarachnoid hemorrhage (SAH), no treatment has yet been established for this condition. This study investigated the efficacy of continuous direct infusion of magnesium sulfate (MgSO4<\/jats:sub>) solution into the intrathecal cistern in patients with an aneurysmal SAH.<\/jats:p><\/jats:sec>\n\nMETHODS<\/jats:title>\nAn SAH caused by a ruptured aneurysm was identified on CT scans within 72 hours after SAH onset. All patients were treated by surgical clipping and randomized into 2 groups: a control group of patients undergoing a standard treatment and a magnesium (Mg) group of patients additionally undergoing continuous infusion of 5 mmol\/L MgSO4<\/jats:sub> solution for 14 days. The Mg2+<\/jats:sup> concentrations in serum and CSF were recorded daily. Neurological examinations were performed by intensive care clinicians. Delayed cerebral ischemia was monitored by CT or MRI. To assess the effect of the Mg treatment on CV, the CVs were graded on the basis of the relative degree of constriction visible on cerebral angiograms taken on Day 10 after the SAH, and transcranial Doppler ultrasonography was performed daily to measure blood flow velocity in the middle cerebral artery (MCA). Neurological outcomes and mortality rates were evaluated with the Glasgow Outcome Scale and modified Rankin Scale at 3 months after SAH onset.<\/jats:p><\/jats:sec>\n\nRESULTS<\/jats:title>\nSeventy-three patients admitted during the period of April 2008 to March 2013 were eligible and enrolled in this study. Three patients were excluded because of violation of protocol requirements. The 2 groups did not significantly differ in age, sex, World Federation of Neurosurgical Societies grade, or Fisher grade. In the Mg group, the Mg2+<\/jats:sup> concentration in CSF gradually increased from Day 4 after initiation of the continuous MgSO4<\/jats:sub> intrathecal administration. No such increase was observed in the control group. No significant changes in the serum Mg2+<\/jats:sup> levels were observed for 14 days, and no cardiovascular complications such as bradycardia or hypotension were observed in any of the patients. However, bradypnea was noted among patients in the Mg group. The Mg group had a significantly better CV grade than the control group (p < 0.05). Compared with the patients in the Mg group, those in the control group had a significantly elevated blood flow velocity in the MCA. Both groups were similar in the incidences of cerebral infarction, and the 2 groups also did not significantly differ in clinical outcomes.<\/jats:p><\/jats:sec>\n\nCONCLUSIONS<\/jats:title>\nContinuous cisternal irrigation with MgSO4<\/jats:sub> solution starting on Day 4 and continuing to Day 14 significantly inhibited CV in patients with aneurysmal SAH without severe cardiovascular complications. However, this improvement in CV neither reduced the incidence of delayed cerebral ischemia nor improved the functional outcomes in patients with SAH.<\/jats:p><\/jats:sec>","DOI":"10.3171\/2015.1.jns142757","type":"journal-article","created":{"date-parts":[[2015,7,31]],"date-time":"2015-07-31T13:59:54Z","timestamp":1438351194000},"page":"18-26","source":"Crossref","is-referenced-by-count":28,"title":["Preventive effect of continuous cisternal irrigation with magnesium sulfate solution on angiographic cerebral vasospasms associated with aneurysmal subarachnoid hemorrhages: a randomized controlled trial"],"prefix":"10.3171","volume":"124","author":[{"given":"Takuji","family":"Yamamoto","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, Juntendo University Shizuoka Hospital, Izunokuni, Shizuoka;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kentaro","family":"Mori","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, National Defense Medical College, Tokorozawa, Saitama; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takanori","family":"Esaki","sequence":"additional","affiliation":[{"name":"Department of Rehabilitation, Gifu Central Hospital, Gifu, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuaki","family":"Nakao","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Juntendo University Shizuoka Hospital, Izunokuni, Shizuoka;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joji","family":"Tokugawa","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Juntendo University Shizuoka Hospital, Izunokuni, Shizuoka;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuya","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Juntendo University Shizuoka Hospital, Izunokuni, Shizuoka;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1754","reference":[{"key":"b1-jns142757","series-title":"J Neurointerv Surg","article-title":"Results of a national cerebrovascular neurosurgery survey on the management of cerebral vasospasm\/delayed cerebral ischemia","author":"Bulsara","year":"2014"},{"issue":"3 Suppl","key":"b2-jns142757","series-title":"Stroke","first-page":"S86","article-title":"Subarachnoid hemorrhage: is it time for a new direction?","volume":"40","author":"Cahill","year":"2009"},{"key":"b3-jns142757","series-title":"J Clin Neurosci","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1054\/jocn.2001.1039","article-title":"Magnesium: a useful adjunct in the prevention of cerebral vasospasm following aneurysmal subarachnoid haemorrhage","volume":"9","author":"Chia","year":"2002"},{"key":"b4-jns142757","series-title":"Neuroradiology","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1007\/s00234-009-0575-y","article-title":"Relationship between vasospasm, cerebral perfusion, and delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage","volume":"51","author":"Dankbaar","year":"2009"},{"key":"b5-jns142757","series-title":"Int J Stroke","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1111\/j.1747-4949.2008.00168.x","article-title":"Magnesium in aneurysmal subarachnoid hemorrhage (MASH II) phase III clinical trial MASH-II study group","volume":"3","author":"Dorhout Mees","year":"2008"},{"key":"b6-jns142757","series-title":"Lancet","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/S0140-6736(12)60724-7","article-title":"Magnesium for aneurysmal subarachnoid haemorrhage (MASH-2): a randomised placebocontrolled trial","volume":"380","author":"Dorhout Mees","year":"2012"},{"key":"b7-jns142757","series-title":"Curr Opin Crit Care","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1097\/00075198-200204000-00007","article-title":"Therapeutic approaches to vasospasm in subarachnoid hemorrhage","volume":"8","author":"Dorsch","year":"2002"},{"key":"b8-jns142757","series-title":"Brain","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.1093\/brain\/awp102","article-title":"Cortical spreading ischaemia is a novel process involved in ischaemic damage in patients with aneurysmal subarachnoid haemorrhage","volume":"132","author":"Dreier","year":"2009"},{"key":"b9-jns142757","series-title":"J Cereb Blood Flow Metab","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1038\/jcbfm.2011.7","article-title":"Effect of pharmaceutical treatment on vasospasm, delayed cerebral ischemia, and clinical outcome in patients with aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis","volume":"31","author":"Etminan","year":"2011"},{"key":"b10-jns142757","series-title":"Neurosurgery","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1227\/01.NEU.0000255396.23280.31","article-title":"Predictors of cerebral infarction in patients with aneurysmal subarachnoid hemorrhage","volume":"60","author":"Fergusen","year":"2007"},{"key":"b11-jns142757","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"723","DOI":"10.3171\/jns.1988.69.5.0723","article-title":"Effect of intrathecal thrombolytic therapy on subarachnoid clot and chronic vasospasm in a primate model of SAH","volume":"69","author":"Findlay","year":"1988"},{"key":"b12-jns142757","series-title":"Neurosurgery","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1227\/01.NEU.0000359530.04529.07","article-title":"Clinical response to hypertensive hypervolemic therapy and outcome after subarachnoid hemorrhage","volume":"66","author":"Frontera","year":"2010"},{"key":"b13-jns142757","series-title":"Transl Stroke Res","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1007\/s12975-013-0257-2","article-title":"Early brain injury, an evolving frontier in subarachnoid hemorrhage research","volume":"4","author":"Fujii","year":"2013"},{"key":"b14-jns142757","series-title":"Clin Biochem","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/S0009-9120(96)00091-4","article-title":"Reference interval for whole blood ionized magnesium in a healthy population and the stability of ionized magnesium under varied laboratory conditions","volume":"29","author":"Greenway","year":"1996"},{"key":"b15-jns142757","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"37","DOI":"10.3171\/jns.1990.73.1.0037","article-title":"The International Cooperative Study on the Timing of Aneurysm Surgery. Part 2: Surgical results","volume":"73","author":"Kassell","year":"1990"},{"key":"b16-jns142757","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"458","DOI":"10.3171\/JNS\/2008\/108\/3\/0458","article-title":"High-dose intraarterial verapamil in the treatment of cerebral vasospasm after aneurysmal subarachnoid hemorrhage","volume":"108","author":"Keuskamp","year":"2008"},{"key":"b17-jns142757","series-title":"Surg Neurol","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/S0090-3019(00)00258-5","article-title":"Cisternal irrigation with UK to prevent vasospasm","volume":"54","author":"Kodama","year":"2000"},{"key":"b18-jns142757","series-title":"Life Sci","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/S0024-3205(02)01738-1","article-title":"Effects of magnesium sulfate on energy metabolites and glutamate in the cortex during focal cerebral ischemia and reperfusion in the gerbil monitored by a dual-probe microdialysis technique","volume":"71","author":"Lin","year":"2002"},{"key":"b19-jns142757","series-title":"Crit Care","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1186\/cc11822","article-title":"Endothelin antagonists in subarachnoid hemorrhage: what next?","volume":"16","author":"Macdonald","year":"2012"},{"key":"b20-jns142757","series-title":"Lancet Neurol","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/S1474-4422(11)70108-9","article-title":"Clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid haemorrhage undergoing surgical clipping: a randomised, doubleblind, placebo-controlled phase 3 trial (CONSCIOUS-2)","volume":"10","author":"Macdonald","year":"2011"},{"issue":"3","key":"b21-jns142757","series-title":"Neurosurg Focus","first-page":"E9","article-title":"A review of current and future medical therapies for cerebral vasospasm following aneurysmal subarachnoid hemorrhage","volume":"21","author":"Mocco","year":"2006"},{"key":"b22-jns142757","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"73","DOI":"10.3171\/2008.4.17494","article-title":"Novel vasodilatory effect of intracisternal injection of magnesium sulfate solution on spastic cerebral arteries in the canine two-hemorrhage model of subarachnoid hemorrhage","volume":"110","author":"Mori","year":"2009"},{"key":"b23-jns142757","series-title":"Acta Neurochir Suppl","first-page":"39","article-title":"Temporal profile of the effects of intracisternal injection of magnesium sulfate solution on vasodilation of spastic cerebral arteries in the canine SAH model","volume":"110","author":"Mori","year":"2011"},{"key":"b24-jns142757","series-title":"Neurosurg Rev","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s10143-008-0122-z","article-title":"Intracisternal infusion of magnesium sulfate solution improved reduced cerebral blood flow induced by experimental subarachnoid hemorrhage in the rat","volume":"31","author":"Mori","year":"2008"},{"key":"b25-jns142757","series-title":"Br J Neurosurg","doi-asserted-by":"publisher","first-page":"64","DOI":"10.3109\/02688697.2011.591948","article-title":"Effect of intrathecal magnesium sulfate solution injection via a microcatheter in the cisterna magna on cerebral vasospasm in the canine subarachnoid haemorrhage model","volume":"26","author":"Mori","year":"2012"},{"key":"b26-jns142757","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.3171\/2010.10.JNS10866","article-title":"Optimal cerebrospinal fluid magnesium ion concentration for vasodilatory effect and duration after intracisternal injection of magnesium sulfate solution in a canine subarachnoid hemorrhage model","volume":"114","author":"Mori","year":"2011"},{"key":"b27-jns142757","series-title":"Brain Res","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.brainres.2012.07.039","article-title":"Novel neuroprotective effect of cisternal and intra-cerebral magnesium sulfate solution infusion on delayed cerebral death in rat hippocampal neurons after transient global ischemia","volume":"1480","author":"Mori","year":"2012"},{"key":"b28-jns142757","series-title":"Neurol Med Chir (Tokyo)","doi-asserted-by":"publisher","first-page":"139","DOI":"10.2176\/nmc.49.139","article-title":"Initial clinical experience of vasodilatory effect of intra-cisternal infusion of magnesium sulfate for the treatment of cerebral vasospasm after aneurysmal subarachnoid hemorrhage","volume":"49","author":"Mori","year":"2009"},{"key":"b29-jns142757","series-title":"Lancet","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/S0140-6736(04)15490-1","article-title":"Magnesium for acute stroke (Intravenous Magnesium Efficacy in Stroke trial): randomised controlled trial","volume":"363","author":"Muir","year":"2004"},{"key":"b30-jns142757","series-title":"Surg Neurol","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.surneu.2007.07.015","article-title":"Magnesium sulfate in the management of patients with aneurysmal subarachnoid hemorrhage: a randomized, placebo-controlled, dose-adapted trial","volume":"69","author":"Muroi","year":"2008"},{"key":"b31-jns142757","series-title":"Neurol Res Int","first-page":"943914","article-title":"The role of magnesium in the management of cerebral vasospasm","volume":"2013","author":"Odom","year":"2013"},{"key":"b32-jns142757","series-title":"Stroke","doi-asserted-by":"publisher","first-page":"1862","DOI":"10.1161\/01.STR.0000133132.76983.8e","article-title":"Predictors of cerebral infarction in aneurysmal subarachnoid hemorrhage","volume":"35","author":"Rabinstein","year":"2004"},{"key":"b33-jns142757","series-title":"Stroke","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1161\/01.STR.31.6.1256","article-title":"Urokinase cisternal irrigation therapy for prevention of symptomatic vasospasm after aneurysmal subarachnoid hemorrhage: a study of urokinase concentration and the fibrinolytic system","volume":"31","author":"Sasaki","year":"2000"},{"key":"b34-jns142757","series-title":"Neurosurgery","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1227\/01.NEU.0000215868.40441.D9","article-title":"Intravenous magnesium versus nimodipine in the treatment of patients with aneurysmal subarachnoid hemorrhage: a randomized study","volume":"58","author":"Schmid-Elsaesser","year":"2006"},{"key":"b35-jns142757","series-title":"Mol Neurobiol","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s12035-010-8155-z","article-title":"Metamorphosis of subarachnoid hemorrhage research: from delayed vasospasm to early brain injury","volume":"43","author":"Sehba","year":"2011"},{"key":"b36-jns142757","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"571","DOI":"10.3171\/jns.1992.76.4.0571","article-title":"Effect of AT877 on cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Results of a prospective placebo-controlled double-blind trial","volume":"76","author":"Shibuya","year":"1992"},{"key":"b37-jns142757","series-title":"Surg Neurol","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.surneu.2006.10.037","article-title":"A postmarketing surveillance study of fasudil treatment after aneurysmal subarachnoid hemorrhage","volume":"68","author":"Suzuki","year":"2007"},{"key":"b38-jns142757","series-title":"BMC Neurol","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1186\/s12883-014-0176-1","article-title":"Effects of intravenous infusion of hydrogen-rich fluid combined with intra-cisternal infusion of magnesium sulfate in severe aneurysmal subarachnoid hemorrhage: study protocol for a randomized controlled trial","volume":"14","author":"Takeuchi","year":"2014"},{"key":"b39-jns142757","series-title":"Eur J Pharmacol","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/0014-2999(78)90303-5","article-title":"Extracellular magnesium ions control calcium exchange and content of vascular smooth muscle","volume":"52","author":"Turlapaty","year":"1978"},{"key":"b40-jns142757","series-title":"Stroke","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1161\/01.STR.0000160801.96998.57","article-title":"Magnesium sulfate in aneurysmal subarachnoid hemorrhage: a randomized controlled trial","volume":"36","author":"van den Bergh","year":"2005"},{"key":"b41-jns142757","series-title":"Magnes Res","first-page":"301","article-title":"Potentials of magnesium treatment in subarachnoid haemorrhage","volume":"17","author":"van den Bergh","year":"2004"},{"key":"b42-jns142757","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"416","DOI":"10.3171\/jns.2002.97.2.0416","article-title":"Role of magnesium in the reduction of ischemic depolarization and lesion volume after experimental subarachnoid hemorrhage","volume":"97","author":"van den Bergh","year":"2002"},{"key":"b43-jns142757","series-title":"Lancet","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/S0140-6736(12)60784-3","article-title":"Magnesium and neuroprotection in subarachnoid haemorrhage","volume":"380","author":"Venkatasubba Rao","year":"2012"},{"key":"b44-jns142757","series-title":"J Cereb Blood Flow Metab","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1038\/jcbfm.2008.74","article-title":"Microthrombosis after aneurysmal subarachnoid hemorrhage: an additional explanation for delayed cerebral ischemia","volume":"28","author":"Vergouwen","year":"2008"},{"key":"b45-jns142757","series-title":"Crit Care Med","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1097\/CCM.0b013e3181d9da1e","article-title":"Prophylactic intravenous magnesium sulfate for treatment of aneurysmal subarachnoid hemorrhage: a randomized, placebo-controlled, clinical study","volume":"38","author":"Westermaier","year":"2010"},{"key":"b46-jns142757","series-title":"Crit Care","doi-asserted-by":"publisher","first-page":"R52","DOI":"10.1186\/cc10017","article-title":"Intravenous magnesium sulphate for aneurysmal subarachnoid hemorrhage: an updated systemic review and meta-analysis","volume":"15","author":"Wong","year":"2011"},{"key":"b47-jns142757","series-title":"Lancet Neurol","first-page":"871872","article-title":"Clazosentan for patients with subarachnoid haemorrhage: lessons learned","volume":"10","author":"Wong","year":"2011"},{"key":"b48-jns142757","series-title":"Stroke","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1161\/STROKEAHA.109.571125","article-title":"Intravenous magnesium sulphate for aneurysmal subarachnoid hemorrhage (IMASH): a randomized, double-blinded, placebo-controlled, multicenter phase III trial","volume":"41","author":"Wong","year":"2010"},{"key":"b49-jns142757","series-title":"World Neurosurg","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.wneu.2010.04.002","article-title":"Efficacy of low-dose tissue-plasminogen activator intracisternal administration for the prevention of cerebral vasospasm after subarachnoid hemorrhage","volume":"73","author":"Yamamoto","year":"2010"}],"container-title":["Journal of Neurosurgery"],"original-title":[],"link":[{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg\/124\/1\/article-p18.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg\/124\/1\/article-p18.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg\/124\/1\/article-p18.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,9]],"date-time":"2024-03-09T09:59:48Z","timestamp":1709978388000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg\/124\/1\/article-p18.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":49,"journal-issue":{"issue":"1"},"URL":"https:\/\/doi.org\/10.3171\/2015.1.jns142757","relation":{},"ISSN":["0022-3085","1933-0693"],"issn-type":[{"value":"0022-3085","type":"print"},{"value":"1933-0693","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1]]}}}